SCHEMBL8745985

SCHEMBL8745985

CC(C)OC(C=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17589372 0.83 AKR1B1 (0.35)
SCHEMBL20256972 0.83 AKR1B1 (0.35)
SCHEMBL7675790 0.77
SCHEMBL17309109 0.76 AKR1B1 (0.33)
SCHEMBL9372836 0.76
SCHEMBL9146236 0.75
SCHEMBL14845625 0.74 AKR1B1 (0.33)
SCHEMBL3503633 0.74
SCHEMBL9070722 0.74
SCHEMBL19660577 0.73 AKR1B1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2392580-A1 2'-fluoronucleosides Emory University (US) 2011-12-07 EP disclosed
EP-2390257-A1 2'-fluoronucleosides Emory University (US) 2011-11-30 EP disclosed
EP-0605078-B1 5,6,7,9-Tetrahydro-1,2,3-trimethoxy-9-oxobenzo alpha heptalene derivative OHGEN RESEARCH LAB LTD (JP) 1997-02-05 EP disclosed
EP-0605078-A1 5,6,7,9-Tetrahydro-1,2,3-trimethoxy-9-oxobenzo alpha heptalene derivative OHGEN RESEARCH LABORATORIES LTD., (JP) 1994-07-06 EP disclosed
US-5326786-A Antimetastasis and anticarcinogenic agents; leukemia OHGEN RESEARCH LABORATORIES LTD. (JP) 1994-07-05 US disclosed